Temporal stability of MGMT promoter methylation in glioblastoma patients undergoing STUPP protocol-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Temporal stability of MGMT promoter methylation in glioblastoma patients undergoing STUPP protocol

Published:2017-12-20 Issue:2 Volume:137 Page:233-240
ISSN:0167-594X
Container-title:Journal of Neuro-Oncology
language:en
Short-container-title:J Neurooncol

Author:

O’Regan C. J.,Kearney H.,Beausang A.,Farrell M. A.,Brett F. M.,Cryan J. B.,Loftus T. E.,Buckley P. G.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Neurology (clinical),Neurology,Oncology

Link

http://link.springer.com/article/10.1007/s11060-017-2722-3/fulltext.html

Reference33 articles.

1. Weller M, van den Bent M, Hopkins K, Tonn JC, Stupp R, Falini A (2014) EANO guideline for the diagnosis and treatment of anaplastic gliomas and glioblastoma. Lancet Oncol 15:e395–e403

2. Thakkar JP, Dolecek TA, Horbinski C, Ostrom QT, Lightner DD, Barnholtz-Sloan JS, Villano JL (2014) Epidemiologic and molecular prognostic review of glioblastoma. Cancer Epidemiol Biomarkers Prev 23(10):1985–1996

3. Stupp R, Hegi ME et al (2009) Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 10(5):459–466

4. Donson AM, Addo-Yobo SO, Handler MH, Gore L, Foreman NK (2007) MGMT promoter methylation correlates with survival benefit and sensitivity to temozolomide in pediatric glioblastoma. Pediatr Blood Cancer 48(4):403–407

5. Dunn J, Baborie A, Alam F, Joyce K, Moxham M, Sibson R, Crooks D, Husband D, Shenoy A, Brodbelt A, Wong H, Liloglou T, Haylock B, Walker C (2009) Extent of MGMT promoter methylation correlates with outcome in glioblastomas given temozolomide and radiotherapy. Br J Cancer 101(1):124–131

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epigenetic Characteristics in Primary and Recurrent Glioblastoma—Influence on the Clinical Course;Biomedicines;2024-09-12

2. Quantitative analysis of MGMT promoter methylation status changes by pyrosequencing in recurrent glioblastoma;Neuropathology;2022-12-11

3. CHANGES IN THE MGMT GENE EXPRESSION IN PATIENTS WITH PRIMARY GLIOBLASTOMA AFTER RELAPSE. INFLUENCE OF CLINICAL CHARACTERISTICS AND MGMT EXPRESSION ON SURVIVAL OF PATIENTS;Siberian journal of oncology;2021-06-29

4. Revealing the epigenetic effect of temozolomide on glioblastoma cell lines in therapeutic conditions;PLOS ONE;2020-02-26

5. Drug resistance in glioblastoma: are persisters the key to therapy?;Cancer Drug Resistance;2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3